TLDR
- Procter & Gamble delivered fiscal Q3 2026 adjusted earnings of $1.59 per share, surpassing the $1.56 consensus
- Quarterly sales reached $21.24 billion, exceeding analyst projections of $20.5 billion
- Unit volume climbed 2% versus prior year — marking the first volume increase in twelve months
- Beauty category outperformed with 5% volume expansion; grooming and health care segments declined
- Company maintained annual outlook, anticipating EPS expansion of 1%–6%
Procter & Gamble delivered impressive fiscal third-quarter results on Friday, surpassing expectations on both the top and bottom lines. Shares jumped approximately 4% during premarket hours in response to the announcement.
The Procter & Gamble Company, PG
The consumer goods giant recorded adjusted earnings per share of $1.59, eclipsing the Street’s $1.56 projection. Sales totaled $21.24 billion, representing a 7% year-over-year increase and comfortably exceeding the $20.5 billion analyst consensus.
Organic revenue, which excludes foreign exchange fluctuations, mergers and dispositions, advanced 3%.
Perhaps the most encouraging data point was unit volume performance. P&G registered 2% volume expansion during the period — representing the first instance of company-wide volume growth in twelve months.
For a consumer staples powerhouse like P&G, volume carries greater significance than top-line revenue. It eliminates pricing distortions and provides clearer insight into underlying consumer demand.
Chief Financial Officer Andre Schulten characterized the American consumer as “stable,” though he acknowledged ongoing bifurcation among different income segments. Translation: budget-conscious households continue facing headwinds.
The beauty division — featuring brands like Olay, Head & Shoulders and Pantene — emerged as the quarter’s champion. It delivered 5% volume growth, with strength spanning personal care, skin care and hair care categories.
Baby, feminine and family care recorded 3% volume gains, powered by stronger diaper demand and family care products such as Bounty and Charmin.
Fabric and home care, anchored by Tide, achieved 2% volume growth, supported by North American strength.
Where It Struggled
Several divisions failed to maintain momentum. Grooming — encompassing Gillette and Venus — experienced a 2% volume contraction. Health care, which includes Oral-B and Vicks, similarly declined 2%.
Operating margin registered 21.5%, down from 23.3% in the comparable year-ago quarter. Gross margin also fell short of analyst estimates, a development worthy of attention.
What’s Ahead
P&G confirmed its annual guidance. Management projects revenue growth of 1%–5% and net earnings per share expansion of 1%–6%, with full-year adjusted EPS guidance centered at $6.96.
Chief Executive Shailesh Jejurikar indicated the company plans to boost investment aimed at strengthening consumer engagement despite persistent economic uncertainty.
One challenge anticipated for Q4: an estimated $150 million expense increase, primarily attributable to elevated transportation costs linked to rising fuel prices.
Free cash flow margin remained stable at 14.3%, approximately matching last year’s comparable period.
Shares traded up roughly 2.6% to $149.47 immediately following the earnings release, before climbing to approximately 4% higher in premarket activity.
